Artificial neural networks to optimize formulation components of a fixed-dose combination of rifampicin, isoniazid and pyrazinamide in a microemulsion.

Source:http://linkedlifedata.com/resource/pubmed/id/16472228

Download in:

View as

General Info

PMID
16472228